跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,451 条关于
“Nanjing IASO Biotechnology”
全部
6,451
临床试验
1,072
药物
930
机构
282
资讯
4,167
10个月前
IASO Bio Partners with GC Cell to Bring First Fully Human BCMA CAR-T Therapy to South Korea
去年
Simcere's Sanbexin Receives FDA Breakthrough Therapy Designation for Acute Ischemic Stroke
前天
FDA Clears IND for IASO208, First China-Originated In Vivo CAR-T to Enter US Clinic
5个月前
IASO Bio Receives Japan PMDA Approval for Phase III CAR-T Trial in Earlier-Line Multiple Myeloma
10个月前
WellsCare Expands IASO Wearable Cold-Laser Therapy to Thailand Through Strategic Partnership
11个月前
IASO Bio Receives Japanese Regulatory Approval for BCMA CAR-T Clinical Trial
2年前
IASO Bio Secures FDA Approval for BCMA CAR-T Therapy in Multiple Autoimmune Diseases
5个月前
IASO Bio Partners with Instituto Butantan to Bring CAR-T Cell Therapy to Brazil's Public Health System
去年
IASO Bio's CAR-T Therapy, Equecabtagene Autoleucel, Advances in Hong Kong and Singapore for Multiple Myeloma
8个月前
Nanjing Delova's QP-6211 Achieves Primary Endpoints in Phase 3 Trials for Postoperative Pain Management
第 1 页,共 417 页
上一页
下一页